HLS Therapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 13.98% vs -5.10% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 64.81% vs -42.11% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.20",
          "val2": "18.60",
          "chgp": "13.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.90",
          "val2": "5.70",
          "chgp": "38.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "3.40",
          "chgp": "-61.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "-0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.90",
          "val2": "-5.40",
          "chgp": "64.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.60%",
          "val2": "-101.70%",
          "chgp": "11.73%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.13% vs -8.81% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 35.32% vs 27.69% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "77.50",
          "val2": "77.60",
          "chgp": "-0.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.70",
          "val2": "20.60",
          "chgp": "19.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.90",
          "val2": "13.80",
          "chgp": "-28.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.90",
          "val2": "-2.10",
          "chgp": "9.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.40",
          "val2": "-26.90",
          "chgp": "35.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-74.00%",
          "val2": "-135.70%",
          "chgp": "6.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

21.20

18.60

13.98%

Operating Profit (PBDIT) excl Other Income

7.90

5.70

38.60%

Interest

1.30

3.40

-61.76%

Exceptional Items

-0.70

-0.70

Consolidate Net Profit

-1.90

-5.40

64.81%

Operating Profit Margin (Excl OI)

15.60%

-101.70%

11.73%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 13.98% vs -5.10% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 64.81% vs -42.11% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

77.50

77.60

-0.13%

Operating Profit (PBDIT) excl Other Income

24.70

20.60

19.90%

Interest

9.90

13.80

-28.26%

Exceptional Items

-1.90

-2.10

9.52%

Consolidate Net Profit

-17.40

-26.90

35.32%

Operating Profit Margin (Excl OI)

-74.00%

-135.70%

6.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -0.13% vs -8.81% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 35.32% vs 27.69% in Dec 2024

All Annual Results